Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer

Ma, SQ; Zhang, L; Ren, Y; Dai, W; Chen, TQ; Luo, LP; Zeng, J; Mi, K; Lang, JY; Cao, BR

Lang, JY; Cao, BR (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China.; Cao, BR (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Biobank, Chengdu, Peoples R China.

ONCOGENE, 2021; 40 (14): 2596

Abstract

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective against non-small cell lung cancer (NSCLC) with EGFR-activating ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索